ARCHIVES

NCAB Accepts Report, Seeks Comment From Researchers, Patient Groups

This article is from The Cancer Letter archive.

Vol. 21 No. 20 | May 19, 1995

Download PDF Visit The Full Archive

Related Articles

IOM Report Links Agent Orange, CLL

January 24, 2003

Senate Subcommittee Gives NCI 41.397 Billion for FY ‘87

August 8, 1986

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

June 27, 2008

NCI Bypass Budget Calls For $5.98 Billion

December 6, 2002

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

In Brief: Ross, Harvey To Lead Cancer Center Group; NCI Director In Office By Aug. 1, Varmus Says

May 19, 1995